Cargando…

Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin‐treated Type 2 diabetes mellitus

AIM: To determine participant knowledge and reporting of hypoglycaemia in the non‐interventional Hypoglycaemia Assessment Tool (HAT) study. METHODS: HAT was conducted in 24 countries over a 6‐month retrospective/4‐week prospective period in 27 585 adults with Type 1 or insulin‐treated Type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khunti, K., Cigrovski Berković, M., Ludvik, B., Moberg, E., Barner Lekdorf, J., Gydesen, H., Pedersen‐Bjergaard, U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099252/ https://www.ncbi.nlm.nih.gov/pubmed/29729048 http://dx.doi.org/10.1111/dme.13662

Ejemplares similares

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study
por: Khunti, K., et al.
Publicado: (2016)

Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real‐world studies
por: Pedersen‐Bjergaard, Ulrik, et al.
Publicado: (2018)

Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2021)

The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis
por: Mrzljak, Anna, et al.
Publicado: (2022)

Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)

Planar hall-effect of the plates types SBV 601, SBV 601-S1, SBV 585 and SBV 585-S1
por: Braunersreuther E
Publicado: (1978)

Hypoglycaemia among Insulin-Treated Patients with Diabetes: Southeast Asia Cohort of IO HAT Study
por: Pathan, Faruque, et al.
Publicado: (2018)

The Effects of Transition from Bedtime to Morning Glargine Administration in Patients with Poorly Regulated Type 1 Diabetes Mellitus: Croatian Pilot Study
por: Gradiser, Marina, et al.
Publicado: (2015)

A longitudinal study of fear of hypoglycaemia in adults with type 1 diabetes
por: Anderbro, Therese Carin, et al.
Publicado: (2018)

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
por: Kristensen, Peter Lommer, et al.
Publicado: (2012)

Hypoglycaemia is reduced with use of inhaled Technosphere(®) Insulin relative to insulin aspart in type 1 diabetes mellitus
por: Seaquist, E. R., et al.
Publicado: (2019)

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
por: Pieber, Thomas R., et al.
Publicado: (2017)

Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
por: Pavlou, Panagiotis, et al.
Publicado: (2021)

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
por: Agesen, Rikke Mette, et al.
Publicado: (2019)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

Hypoglycaemia in Type 2 diabetes
por: Amiel, S A, et al.
Publicado: (2008)

A meta‐analysis of rate ratios for nocturnal confirmed hypoglycaemia with insulin degludec vs. insulin glargine using different definitions for hypoglycaemia
por: Heller, S., et al.
Publicado: (2015)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used
por: Norwood, Paul, et al.
Publicado: (2017)

Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
por: Kristensen, Peter L, et al.
Publicado: (2016)

Insulin Hypoglycæmia
Publicado: (1948)

Research: Adolescents with Type 1 diabetes mellitus experience psychosensorial symptoms during hypoglycaemia
por: Law, J R, et al.
Publicado: (2014)

585. Shifting Focus Toward Healthcare-Associated Bloodstream Infections: Need for More NICU-Specific NHSN Definitions
por: Advani, Sonali D, et al.
Publicado: (2019)

Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2020)

SAT-585 Autoregulation of Adipose Tissue Development
por: Feldman, Brian, et al.
Publicado: (2020)

The effectiveness of lixisenatide as an add on therapy to basal insulin in diabetic type 2 patients previously treated with different insulin regimes: a multi-center observational study
por: Božek, Tomislav, et al.
Publicado: (2018)

Fear of hypoglycaemia among patients with type 2 diabetes mellitus: a cross-sectional study
por: Wang, Yanhao, et al.
Publicado: (2021)

Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application
por: Søholm, Uffe, et al.
Publicado: (2022)

Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
por: Elvebakk, Ole, et al.
Publicado: (2018)

Clinical research of insulin glargine U300 in type 1 diabetes mellitus patients with frequent hypoglycaemia: real-world experience
por: Kişioğlu, Savaş Volkan, et al.
Publicado: (2021)

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia
por: Reviriego, J, et al.
Publicado: (2008)

Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
por: Philis-Tsimikas, Athena, et al.
Publicado: (2020)

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
por: Bilic Curcic, Ines, et al.
Publicado: (2021)

Semaglutide-eye-catching results
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2023)

Reduced hypoglycaemia using liver‐targeted insulin in individuals with type 1 diabetes
por: Weinstock, Ruth S., et al.
Publicado: (2022)

What is the gut feeling telling us about physical activity in colorectal carcinogenesis?
por: Berkovic, Maja Cigrovski, et al.
Publicado: (2020)

NAFLD and Physical Exercise: Ready, Steady, Go!
por: Cigrovski Berkovic, Maja, et al.
Publicado: (2021)

The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes
por: Dunn, Joel T., et al.
Publicado: (2018)

Limited impact of impaired awareness of hypoglycaemia and severe hypoglycaemia on the inflammatory profile of people with type 1 diabetes
por: Ali, Namam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_28dqh06k22lb7ihu40i1s6ocfn